Antibiotic use and inflammatory bowel disease: number needed to harm? Authors' reply

被引：0
|
作者：
Faye, Adam S. [1 ,2 ,4 ]
Jess, Tine [2 ,3 ]
机构：
[1] New York Univ, Dept Med & Populat Hlth, Grossman Sch Med, New York, NY USA
[2] Aalborg Univ, Ctr Mol Predict Inflammatory Bowel Dis, Dept Clin Med, Copenhagen, Denmark
[3] Aalborg Univ, Dept Gastroenterol & Hepatol, Aalborg, Denmark
[4] New York Univ, Grossman Sch Med, New York, NY 10016 USA
来源：
GUT | 2023年
关键词：
IBD; ANTIBIOTICS; CROHN'S DISEASE; ULCERATIVE COLITIS;
D O I：
10.1136/gutjnl-2023-329851
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Letter: fulminant onset complicated inflammatory bowel disease (IBD) - a unique subtype? Authors' reply
    Jayasooriya, Nishani
    Saxena, Sonia
    Pollok, Richard C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (10) : 1194 - 1195
  • [42] Editorial: migration studies to determine risk and cause of inflammatory bowel disease-authors' reply
    Damas, Oriana M.
    Schwartz, Seth J.
    Abreu, Maria T.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (04) : 467 - 467
  • [43] Commentary: ursodeoxycholic acid as chemoprevention in inflammatory bowel disease and primary sclerosing cholangitis - authors' reply
    Lindstrom, L.
    Bergquist, A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (07) : 847 - 847
  • [44] Increased health burden associated with Clostridium difficile diarrhoea in inflammatory bowel disease: authors' reply
    Pollok, R. C. G.
    Saxena, S.
    Jen, M-H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (03) : 395 - 396
  • [45] Letter: suicide risk among adult inflammatory bowel disease patients. Authors' reply
    Malham, Mikkel
    Jakobsen, Christian
    Paerregaard, Anders
    Hald, Mette
    Virta, Lauri
    Kolho, Kaija-Leena
    Wewer, Vibeke
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (11) : 1214 - 1215
  • [46] Letter: phenotype and natural history of elderly onset inflammatory bowel disease-Authors' reply
    Manosa, M.
    Domenech, E.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (10) : 1421 - 1422
  • [47] Editorial: shedding new light on extraintestinal manifestations in inflammatory bowel disease-authors' reply
    Falloon, Katherine
    Cohen, Benjamin
    Rieder, Florian
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (09) : 1208 - 1209
  • [48] Editorial: assessment of inflammatory bowel disease: a picture is worth a thousand words. Authors' reply
    Friedman, Antony B.
    Gibson, Peter R.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (04) : 510 - 510
  • [49] Editorial: opioids in inflammatory bowel disease-primum non nocere. Authors' reply
    Rhudy, Christian
    Perry, Courtney L.
    Barrett, Terrence A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (07) : 846 - 846
  • [50] Letter: Mendelian randomization --new perspective in inflammatory bowel disease and pancreatic cancer? Authors' reply
    Massironi, Sara
    Vigano, Chiara
    Danese, Silvio
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (01) : 145 - 146
12345